Procurement of ready-to-use PET radiopharmaceuticals and therapy products

Summary

The procurement covers ready-to-use PET radiopharmaceuticals and therapy products for the isotope medicine department of Ahvenisto Hospital. It is divided into six lots: F18-FDG, F18-piflufolastat, F18-fluorocholine, F18-fluoride, 177Lu-PSMA and 225Ac-PSMA. Partial tenders are permitted. The procurement establishes a four-year framework agreement, and all suppliers that meet the tender requirements may be admitted. Estimated annual quantities are indicative and do not bind the contracting authority; some products may not be ordered. Orders will generally follow a price-based ranking, with the lowest-priced supplier given priority. The supplier must respond to inquiries within 24 hours, with the response period for weekend and public-holiday inquiries starting on the next working day. The tender deadline is 29 September 2026 at 09:00 UTC.